Phthalocyanine mediated photodynamic thrombosis of experimental corneal neovascularization: effect of phthalocyanine dose and irradiation onset time on vascular occlusion rate.
The aim of this study was to evaluate the possible influence of phthalocyanine dose and of time interval between phthalocyanine injection and irradiation commencement on the rate of experimental corneal neovascularization photodynamic thrombosis in albino rabbits. New corneal vessels were irradiated with a diode laser (670 nm, 2 mW) after the intravenous injection of chloroaluminum sulfonated phthalocyanine. Different animals were irradiated either 5 min after the injection of different phthalocyanine doses (3, 6, 8, 12, or 14 mg/kg), or at different times (5 min, 24 h, or 58 h) after a standard phthalocyanine dose (3 mg/kg) injection. Irradiation time necessary for vascular occlusion was recorded. Decrease of phthalocyanine dose as well as delay of irradiation onset resulted in a statistically significant increase of irradiation time. Electron and light histological examination revealed platelet thrombi inside irradiated corneal new vessels. Damage in the vascular endothelial cell membrane and in intercellular contact structure was noted, leading to disorganization of the endothelial cells layer and death of most endothelial cells. These results indicate that both early commencement of irradiation after phthalocyanine injection and phthalocyanine dose increase accelerate the rate of phthalocyanine mediated corneal neovascularization photodynamic thrombosis. Thrombosis seems to result from photochemically induced vascular endothelial cell damage.
Tsilimbaris
M K
MK
Vardinoyannion Eye Institute of Crete, Department of Ophthalmology, University of Crete, Greece.
Pallikaris
I G
IG
Naoumidi
I I
II
Vlahonikolis
I G
IG
Tsakalof
A K
AK
Lydataki
S E
SE
D000535:Aluminum; D000818:Animals; D003315:Cornea / Q000098:blood supply / Q000528:radiation effects / Q000648:ultrastructure; D016510:Corneal Neovascularization / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D007211:Indoles / Q000627:therapeutic use*; D007275:Injections, Intravenous; D053685:Laser Therapy; D008297:Male; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010778:Photochemotherapy; D011817:Rabbits; D011838:Radiation-Sensitizing Agents; D013927:Thrombosis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D007211:Indoles; D009942:Organometallic Compounds; D011838:Radiation-Sensitizing Agents; C052736:chloroaluminum tetrasulfophthalocyanine; D000535:Aluminum